Results 71 to 80 of about 7,746 (204)

Heparan Sulfate Proteoglycans in Immunity

Proteoglycan Research, Volume 4, Issue 2, April 2026.
ABSTRACT In immune cells, heparin was first identified in mast cells in the 1940s, followed by the discovery of heparan sulfate in lymphocytes and granulocytes during the 1970s and 1980s. Subsequent decades of research have revealed how heparan sulfate and heparin, conjugated to core proteins as heparan sulfate proteoglycans (HSPGs), act as versatile ...
Moe Iwai, Pyong Woo Park
wiley   +1 more source

The impact of oral contraception on vulvovaginal candidiasis [PDF]

, 1995
To evaluate risk factors related to sociodemographic and clinical variables, oral contraception and sexual behavior of women with recurrent vulvovaginal candidiasis, we conducted a case-control study comparing 153 patients with recurrent vulvovaginal ...
Ferrari A, SPINILLO, ARSENIO, Nicola S, Baltaro F, Capuzzo E, Monaco A.   +5 more
core   +1 more source

Vulvovaginal candidiasis [PDF]

International Journal of Gynecology & Obstetrics, 2006
D, Moreira, C R, Paula
openaire   +4 more sources

Pathogenetic aspects and modern possibilities of therapy of vulvovaginal candidiasis [PDF]

Vestnik Dermatologii i Venerologii
The literature review presents modern aspects of the etiology and pathogenesis of vulvovaginal candidiasis, highlights issues of immunological resistance and the significance of polymorphic and pathological gene loci, the functioning of which leads to ...
Margarita R. Rakhmatulina, Elena V. Lipova, Viktoria A. Nyanenko   +2 more
doaj   +1 more source

Evidence‐ and consensus‐based guideline on lichen sclerosus

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 566-584, April 2026.
Summary The German‐language, consensus‐ and evidence‐based S3 guideline on lichen sclerosus (LS) was developed based on the European “EuroGuiDerm Guideline on lichen sclerosus” under the leadership of the German Dermatological Society (DDG) and the German Society for Gynecology and Obstetrics (DGGG).
Gudula Kirtschig, Linn Woelber, Andreas Günthert, Karl Becker, Alexandra Ciresa‐König, Bettina Fischer, Susanne Fricke‐Otto, Claudia Günther, Christine Hirchenhain, Narayani Helga Köllmann, Alexander Kreuter, Bartosz Malisiewicz, Felix Neis, Dan mon O'Dey, Hagen Ott, Martin Promm, Regina Renner, Anne‐Rose Schardt, Ines Schweizer, Raimund Stein, Jan Ter‐Nedden, Gerda Trutnovsky, Agnes Wand, Gerhard Weyandt, Ricardo N. Werner, Maria Kinberger   +25 more
wiley   +1 more source

Treatment of recurrent vulvovaginal candidiasis in women planning a pregnancy [PDF]

РМЖ. Мать и дитя, 2018
Treatment of recurrent vulvovaginal candidiasis in women planning a pregnancy Borovikov I.O., Kutsenko I.I., Gerasimenko E.E. Kuban State Medical University, Krasnodar Aim: evaluation of treatment methods for recurrent vulvovaginal candidiasis ...
Borovikov I.O., Kutsenko I.I., E.E. Gerasimenko   +2 more
doaj  

Evidenz‐ und konsensbasierte (S3) Leitlinie: Lichen sclerosus

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 566-586, April 2026.
Zusammenfassung Die deutschsprachige, konsens‐ und evidenzbasierte S3‐Leitlinie zum Lichen sclerosus (LS) wurde unter Federführung der Deutschen Dermatologischen Gesellschaft e.V. (DDG) und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e.V.
Gudula Kirtschig, Linn Woelber, Andreas Günthert, Karl Becker, Alexandra Ciresa‐König, Bettina Fischer, Susanne Fricke‐Otto, Claudia Günther, Christine Hirchenhain, Narayani Helga Köllmann, Alexander Kreuter, Bartosz Malisiewicz, Felix Neis, Dan mon O'Dey, Hagen Ott, Martin Promm, Regina Renner, Anne‐Rose Schardt, Ines Schweizer, Raimund Stein, Jan Ter‐Nedden, Gerda Trutnovsky, Agnes Wand, Gerhard Weyandt, Ricardo N. Werner, Maria Kinberger   +25 more
wiley   +1 more source

Long‐term safety and efficacy of secukinumab in paediatric severe plaque psoriasis: 236‐week, Phase 3 trial results

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page 617-625, April 2026.
In this Phase III study, secukinumab demonstrated sustained efficacy and a favourable safety profile in paediatric patients with chronic severe plaque psoriasis over a treatment period of 236 weeks. Abstract Background Plaque psoriasis, a chronic inflammatory disease, affects up to 2.1% of the global paediatric population.
Andrzej Kaszuba, Philemon Papanastasiou, Dorota Krasowska, Raul De Lucas Laguna, Michael Ziv, Shoba Ravichandran, Amita Bansal, Swapnil S. Dahale, Ruvie Martin, Bertrand Paguet, Nina Magnolo, Kulli Kingo   +11 more
wiley   +1 more source

Vaginal azoles versus oral fluconazole in treatment of recurrent vulvovaginal candidiasis [PDF]

Background: Vulvovaginal candidiasis (VVC) is a fungal infection of the vagina and vulva. It is usually caused by Candida albicans, however, occasionally other candida species are responsible. The optimal treatment of VVC has not yet been defined.
فردی آذر, زهرا, عبدالهی فرد, صدیقه, تلو, مهشید, حبیب زاده, شهرام   +3 more
core  

Muscle Dysfunction and Bone Loss in a Woman With Cystic Fibrosis and Obesity Treated With Glucagon‐Like Peptide 1 Agonist: A Case Report

Respirology Case Reports, Volume 14, Issue 3, March 2026.
Cystic fibrosis (CF) modulator therapies can lead to rapid and excessive weight gain. Obesity in CF can lead to undesirable metabolic complications including type 2 diabetes. Therefore, glucagon‐like peptide 1 (GLP‐1) agonists which can facilitate weight loss and improve metabolic profiles are increasingly prescribed to people with CF.
Shanal Kumar, Robyn Cobb, Angela Matson, Joseph Lee, Daniel Henderson   +4 more
wiley   +1 more source